SILO PHARMA, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
SILO PHARMA, INC. (SILO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 96.86 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-13
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 96.86M shares, a 175.73% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 85.14M shares, a 260.71% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 85.28M shares, a 262.21% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 84.42M shares, a 259.72% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 65.95M shares, a 181.03% increase from fiscal 2019.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 23.47M shares, a 52.20% decline from fiscal 2018.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 49.10M shares.
- SILO PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 30.63M shares, a 0.00% change from fiscal 2011.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 24 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 27 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 30 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 33 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 36 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 39 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | 96.86M shares 10-Q · filed 2021-08-13 | 91.03M shares 10-Q · filed 2021-08-13 | 89.09M shares derived: average of 3 quarters · filed 2021-08-13 | 87.92M shares derived: average of 4 quarters · filed 2021-08-13 | ||||||
| 2021-03-31 | 85.14M shares 10-Q · filed 2021-05-17 | 85.21M shares derived: average of 2 quarters · filed 2021-05-17 | 84.95M shares derived: average of 3 quarters · filed 2021-05-17 | 72.49M shares derived: average of 4 quarters · filed 2021-08-13 | ||||||
| 2020-12-31 | 85.28M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | 84.85M shares derived: average of 2 quarters · filed 2021-05-17 | 68.28M shares derived: average of 3 quarters · filed 2021-08-13 | 65.95M shares 10-K/A · filed 2021-05-17 | ||||||
| 2020-09-30 | 84.42M shares 10-Q · filed 2020-11-05 | 59.77M shares derived: average of 2 quarters · filed 2021-08-13 | 59.51M shares 10-Q · filed 2020-11-05 | 41.67M shares derived: average of 4 quarters · filed 2021-08-13 | ||||||
| 2020-06-30 | 35.13M shares 10-Q · filed 2021-08-13 | 46.93M shares 10-Q · filed 2021-08-13 | 27.43M shares derived: average of 3 quarters · filed 2021-08-13 | 26.44M shares derived: average of 4 quarters · filed 2021-08-13 | ||||||
| 2020-03-31 | 23.60M shares 10-Q · filed 2021-05-17 | 23.57M shares derived: average of 2 quarters · filed 2021-05-17 | 23.54M shares derived: average of 3 quarters · filed 2021-05-17 | 23.51M shares derived: average of 4 quarters · filed 2021-05-17 | ||||||
| 2019-12-31 | 23.55M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | 23.51M shares derived: average of 2 quarters · filed 2021-05-17 | 23.49M shares derived: average of 3 quarters · filed 2021-05-17 | 23.47M shares 10-K/A · filed 2021-05-17 | ||||||
| 2019-09-30 | 23.47M shares 10-Q · filed 2020-11-05 | 23.46M shares derived: average of 2 quarters · filed 2020-11-05 | 23.44M shares 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | 23.44M shares 10-Q · filed 2020-08-14 | 23.43M shares 10-Q · filed 2020-08-14 | ||||||||
| 2019-03-31 | 23.42M shares 10-Q · filed 2020-05-12 | |||||||||
| 2018-12-31 | 49.10M shares 10-K · filed 2020-03-20 | |||||||||
| 2013-09-30 | 30.73M shares 10-Q · filed 2013-11-14 | 30.73M shares derived: average of 2 quarters · filed 2013-11-14 | 30.70M shares 10-Q · filed 2013-11-14 | 30.68M shares derived: average of 4 quarters · filed 2014-03-31 | 30.51M shares 10-Q · filed 2013-11-14 | |||||
| 2013-06-30 | 30.73M shares 10-Q · filed 2013-08-08 | 30.68M shares 10-Q · filed 2013-08-08 | 30.67M shares derived: average of 3 quarters · filed 2014-03-31 | 30.66M shares derived: average of 4 quarters · filed 2014-03-31 | 30.49M shares 10-Q · filed 2013-08-08 | |||||
| 2013-03-31 | 30.63M shares 10-Q · filed 2013-05-15 | 30.63M shares derived: average of 2 quarters · filed 2014-03-31 | 30.63M shares derived: average of 3 quarters · filed 2014-03-31 | 30.63M shares derived: average of 4 quarters · filed 2014-03-31 | 30.46M shares 10-Q · filed 2013-05-15 | |||||
| 2012-12-31 | 30.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 30.63M shares derived: average of 2 quarters · filed 2014-03-31 | 30.63M shares derived: average of 3 quarters · filed 2014-03-31 | 30.63M shares 10-K · filed 2014-03-31 | 30.45M shares 10-K · filed 2013-03-05 | |||||
| 2012-09-30 | 30.63M shares 10-Q · filed 2013-11-14 | 30.63M shares derived: average of 2 quarters · filed 2013-11-14 | 30.63M shares 10-Q · filed 2013-11-14 | 30.63M shares derived: average of 4 quarters · filed 2014-03-31 | 30.43M shares 10-Q · filed 2012-11-13 | |||||
| 2012-06-30 | 30.63M shares 10-Q · filed 2013-08-08 | 30.63M shares 10-Q · filed 2013-08-08 | 30.63M shares derived: average of 3 quarters · filed 2014-03-31 | 30.63M shares derived: average of 4 quarters · filed 2014-03-31 | 30.40M shares 10-Q · filed 2012-08-01 | |||||
| 2012-03-31 | 30.63M shares 10-Q · filed 2013-05-15 | 30.63M shares derived: average of 2 quarters · filed 2014-03-31 | 30.63M shares derived: average of 3 quarters · filed 2014-03-31 | 30.63M shares derived: average of 4 quarters · filed 2014-03-31 | ||||||
| 2011-12-31 | 30.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 30.63M shares derived: average of 2 quarters · filed 2014-03-31 | 30.63M shares derived: average of 3 quarters · filed 2014-03-31 | 30.63M shares 10-K · filed 2014-03-31 | ||||||
| 2011-09-30 | 30.63M shares 10-Q · filed 2012-11-13 | 30.63M shares derived: average of 2 quarters · filed 2012-11-13 | 30.63M shares 10-Q · filed 2012-11-13 | |||||||
| 2011-06-30 | 30.63M shares 10-Q · filed 2012-08-01 | 30.63M shares 10-Q · filed 2012-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |